Australia TGA issues a notice on transition to new GMP requirements for medicinal products

Therapeutic Goods Administration(TGA) of Australia will adopt the current version of the PIC/S Guide to Good Manufacturing Practice for Medicinal …

read more...

TGA Publishes Specification on Release of Information on Clinical Trials of Therapeutic Goods

On June 2020, The Therapeutic Good Administration (TGA ) of Australia has released The Therapeutic Goods (Clinical Trial Inspections) Specification …

read more...

TGA Waives Pre-Approval for Medicine Advertisements in Specified Media

Effective from 1 July 2020, pre-approval from Therapeutic Goods Administration (TGA) is not required for medicine advertisements in selected media. …

read more...

TGA Waives Pre-Approval for Medicine Advertisements in Specified Media

Effective from 1 July 2020, pre-approval from Therapeutic Goods Administration (TGA) is not required for medicine advertisements in selected media. …

read more...

TGA Australia Updates Regulatory Guidelines In Replacement of ARGCM V8.0

The Therapeutic Goods Administration (TGA) of Australia has published in May 2020, new guidelines to replace the existing Australian Regulatory …

read more...

Australia TGA Updates Public Information on Inactive Ingredients in Medicine Formulations

30 April 2020, The Therapeutic Goods Administration (TGA) of Australia has announced the release of important formulations on biological products …

read more...

Australia publishes a new guideline and FAQ on exportation of therapeutic goods

Australia TGA has published information and a new FAQ on exporting therapeutic goods from Australia. In order to export therapeutic …

read more...